Manufacturer record
Nest Healthcare Pvt.Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
10 batches manufactured by Nest Healthcare Pvt.Ltd (Gujarat) were declared Not of Standard Quality between November 2023 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: NHD26176B, Tryspin, Bromelain & Rutoside Trihydrate Dispersible Tablets (exp Jan 2028). DTL, Chennai-06 (state lab) found it not of standard quality: Uniformity of Dispersion. Listed in the August 2026 alert.
Records by type
10 records linked to Nest Healthcare Pvt.Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Tryspin, Bromelain & Rutoside Trihydrate Dispersible Tablets | Batch NHD26176BMfg Feb 2026 · Exp Jan 2028 | Uniformity of DispersionUniformity of weight/content | DTL, Chennai-06State lab | Aug 2026 |
| Methylprednisolone Tablets I.P. | Batch NHD24554AMfg Nov 2024 · Exp Oct 2026 | The sample does not conform to IP with respect to the test for DissolutionDissolution | CDTL, IndoreCDSCO lab | Jul 2026 |
| Metformin Hydrochloride Prolonged Release & Glimepiride Tablets IP,(Ajapride M2) | Batch NHD24148AMfg Mar 2024 · Exp Feb 2027 | Sample fails the test Descriptive Part for the tablets as per IP.Other | DTL Thiruvananthapuram,KeralaState lab | Dec 2025 |
| Atenolol Tablets IP 50 mg | Batch NHD25365AMfg May 2025 · Exp Apr 2027 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Oct 2025 |
| Ramipril Tablets IP 5mg | Batch NHD24605AMfg Dec 2024 · Exp Nov 2026 | Assay of Ramipril.Assay | CDTL, IndoreCDSCO lab | Jul 2025 |
| Metformin Hydrochloride Prolonged Release and Glimepiride Tablets IP "Gli-Me SR2 | Batch NHD24334AMfg Jul 2024 · Exp Jun 2026 | AssayAssay | Drug Control Department ChhattisgarhState lab | Jul 2025 |
| Rabeprazole Sodium Enteric Coated & Domperidone Sustained Release Capsules (Kylid-RD) | Batch NHD24207CMfg May 2024 · Exp Apr 2026 | The sample does not conform to the claim with respect to Assay of Rabeprazole Sodium.Assay | DTL, Jaipur (State Lab)State lab | May 2025 |
| Glibenclamide Tablets IP 5mg | Batch NHD24411AMfg Jul 2024 · Exp Jul 2025 | Sample does not conform to IP specificaion for Glibenclamide Tablets with respec to DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab | May 2025 |
| Pantoprazole Sodium Gastro-Resistant & Domperidone Prolonged-Release Capsules IP (Pengin- DSR Capsules) | Batch NHD24057DMfg Jan 2024 · Exp Dec 2025 | "Dissolution for Domperidone"Dissolution | CDTL-MumbaiCDSCO lab | Mar 2025 |
| AMLODIPINE TABLETS IP 5 mg | Batch NHD22477AMfg Nov 2022 · Exp Oct 2024 | Related SubstancesRelated substances | CDTL HyderabadCDSCO lab | Nov 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.